Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 4 , Pages 394-401, December 2009

Nanomedicines for ocular NSAIDs: safety on drug delivery

  • Joana Araújo, MSc

      Affiliations

    • Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
    • ,
  • Elisabet Gonzalez, MSc

      Affiliations

    • Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
    • ,
  • Maria Antonia Egea, PhD

      Affiliations

    • Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
    • ,
  • Marisa Luisa Garcia, PhD

      Affiliations

    • Department of Physical Chemistry, Institute of Nanoscience and Nanotechnology, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain
    • ,
  • Eliana B. Souto, PhD

      Affiliations

    • Department of Pharmaceutical Technology, Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal
    • Institute of Biotechnology and Bioengineering, Centre of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
    • Corresponding Author InformationCorresponding author: Faculty of Health Sciences, University Fernando Pessoa, 4200-150 Porto, Portugal.

Received 9 December 2008; accepted 13 February 2009. published online 01 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(09)00057-4

doi:10.1016/j.nano.2009.02.003

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 4 , Pages 394-401, December 2009

Article Tools